Skip to main content
Clinical Trials/LBCTR2020074518
LBCTR2020074518
Recruiting
Not Applicable

A Prospective Observational study to describe the pattern and effectiveness of the utilization of different treatment options for Metastatic Renal Cell Carcinoma - OPERA

General Research Grant0 sites185 target enrollmentNovember 11, 2021

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Patients with:-histologically confirmed metastatic renal cell cancer-treated by immunotherapy and/or TKI
Sponsor
General Research Grant
Enrollment
185
Status
Recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
November 11, 2021
End Date
March 30, 2025
Last Updated
last year
Study Type
Observational
Sex
All

Investigators

Sponsor
General Research Grant

Eligibility Criteria

Inclusion Criteria

  • Patients \= 18 years old
  • \-Histologically confirmed metastatic renal cell cancer
  • \-Patients treated by immunotherapy and/or TKI
  • \-Signed informed consent form obtained prior to study entry only for living patients

Exclusion Criteria

  • \-History of another malignancy within the past 5 years except cured basal cell carcinoma of the skin or excised carcinoma in situ of the cervix
  • \-Pregnancy
  • \-Current participation in another clinical trial

Outcomes

Primary Outcomes

Not specified

Similar Trials